A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects

NCT00917267 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

691

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: exenatide once weekly
DRUG: exenatide twice daily

Sponsor

AstraZeneca

Collaborators

[object Object]